Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation. - Wikidata - awgldk - TriplyDB

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.

http://www.wikidata.org/entity/Q37859368

about

Belatacept : a new biological agent for maintenance immunosuppression in kidney transplantation.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Pharmacokinetics of recombinant bifunctional fusion proteins.Current status of immunosuppressive agents for solid organ transplantation in children.Risk evaluation and mitigation strategies: a focus on belatacept.Biologic agents in islet transplantation.Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease.Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation: a case report.Cutaneous Toxicities From Transplantation-Related Medications.Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection.

P2860

Q34638056-CCD98AFB-C34F-4709-9B7D-F6E7FEBE8718 Q34841849-AE50A468-07C9-4220-9F05-E9BB66AFB087 Q37033032-1D33A4BA-1FCB-43EF-B398-F4FDEEA31343 Q37987565-E8A90ADE-E098-4AD4-BCF4-270C32F12D71 Q38085439-AE43241E-2A7F-498D-AA61-5A05761BBB65 Q38126884-C6E69C32-A529-4AF8-B13B-2CC19C571154 Q38400396-81C04C61-1A84-4F27-B4D6-1245AE0D0F09 Q38518588-838DD126-C875-44DF-BC98-F3FEE644B52D Q38593433-BF00265C-B801-4453-A1CC-82EDAF9B4FA7 Q38626369-201347D0-7650-4C4B-839A-536FA19814E1 Q39269082-CE78E6DF-0D73-434C-A3F7-7E167D1A9579 Q42057719-CE77218B-880C-4A75-A1EB-2F2B26EE7A99

P2860

Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.

http://www.wikidata.org/entity/Q37859368

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Belatacept: a novel biologic f ...... n after renal transplantation.

@en

Belatacept: a novel biologic f ...... n after renal transplantation.

@nl

type

label

Belatacept: a novel biologic f ...... n after renal transplantation.

@en

Belatacept: a novel biologic f ...... n after renal transplantation.

@nl

prefLabel

Belatacept: a novel biologic f ...... n after renal transplantation.

@en

Belatacept: a novel biologic f ...... n after renal transplantation.

@nl

P1433

Q37859368-210DE155-8CF1-46A5-AE8C-DDD9BAC9BE7C

P1476

Q37859368-0D13B3F9-DEAB-4998-A0FA-402C3143536B

P2093

Q37859368-BEE129DF-A426-4A16-A8E3-3EA798AD35ED

Q37859368-EA6D894A-4B39-4893-9DC4-8945AD1160A5

P2860

Q37859368-051490D5-7663-4C1D-A9B9-7BDE117432A3

Q37859368-078D676F-55E8-4C47-B124-AF7BDC28645E

Q37859368-11AC8C89-01DC-4A4B-8755-77C43615662D

Q37859368-15C2CBA3-FD27-4E20-86E5-74E816348551

Q37859368-163E86EC-4522-40B8-939E-6E2074BD2236

Q37859368-171FE91A-E98F-42E2-BABE-953E76182ADB

Q37859368-1868C1E5-158D-46AB-A2BA-1D0B4A9361F7

Q37859368-1A2A5203-3AFE-4B9D-AE20-075E3BF411B9

Q37859368-1D9E9E5B-CAF4-4219-8D27-7A7C7C2127DB

Q37859368-1DA69E08-987E-4D19-8635-B5BD4E800F97

P304

Q37859368-76C02A7D-4B74-4CC0-8041-38A80BE02CF1

P31

Q37859368-9D8E68AE-DDAA-417E-93E9-F3AB717D48AE

P356

Q37859368-AE25BA8E-D7BF-4505-8ED1-0A2DDD136D42

P407

Q37859368-790CFDAC-3019-4A75-8824-3B36D89177C5

P433

Q37859368-0D9B0EA7-0F41-4BA0-AFF7-C9EACA4AEA78

P478

Q37859368-F9E76241-45FE-490C-BD8B-61D750770CB1

P50

Q37859368-C986C6D0-9DFE-4AD3-BF6E-09C3C698B6C7

P577

Q37859368-5C33A732-FED9-4F45-B698-9BBD63B83B50

P698

Q37859368-CC30FB5D-B7C8-45DF-9958-BD01B3DDAE2B

P921

Q37859368-C895A26E-82C5-41BC-9444-F6CD0F71A2EF

P356

P1433

Pharmacotherapy

P1476

Belatacept: a novel biologic f ...... n after renal transplantation.

@en

P2093

Eric M Tichy

http://www.w3.org/2001/XMLSchema#string

Spencer T Martin

http://www.w3.org/2001/XMLSchema#string

P2860

CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1

Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.

The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system.

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.

Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview.

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial.

T-cell regulation by CD28 and CTLA-4.

P304

394-407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1592/PHCO.31.4.394

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21449628

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression